Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research focused on Bronchopulmonary dysplasia and Hyperoxia, with related work in Microbiome, Inflammation, Microvesicles. Notable publications include 'Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung', 'The Airway Microbiome at Birth', and 'Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants'.
A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation
Microbial-induced Redox Imbalance in the Neonatal Lung Is Ameliorated by Live Biotherapeutics
Nicotine, smoking, podocytes, and diabetic nephropathy
MicroRNA 219-5p inhibits alveolarization by reducing platelet derived growth factor receptor-alpha
The closed eye harbours a unique microbiome in dry eye disease
Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung
Effects of hyperoxia on alveolar and pulmonary vascular development in germ-free mice
Heterozygous <i>Pkhd1</i><sup>C642*</sup> mice develop cystic liver disease and proximal tubule ectasia that mimics radiographic signs of medullary sponge kidney
Mitochondrial DNA variation modulates alveolar development in newborn mice exposed to hyperoxia
COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease
Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants
The Airway Microbiome at Birth
Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor
The transcription factor ETS-1 regulates angiotensin II-stimulated fibronectin production in mesangial cells